Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 8/20 | 0.56 |
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.51 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601961 | 0.93 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601932 | 0.93 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19582570 | 0.92 | MGLL (0.66) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601924 | 0.92 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601953 | 0.92 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601960 | 0.91 | MGLL (0.54) | MGLL | |
| SCHEMBL19601936 | 0.91 | MGLL (0.58) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601964 | 0.89 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601954 | 0.89 | MGLL (0.60) | MGLLABHD6PLA2G7 | |
| SCHEMBL19601962 | 0.89 | MGLL (0.57) | MGLLABHD6PLA2G7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10030020-B2 | Spirocycle compounds and methods of making and using same | ABIDE THERAPEUTICS, INC. (US) | 2018-07-24 | — | — | US | disclosed |
| US-20170327500-A1 | SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME | H. LUNDBECK A/S (DK) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327500-A1 | SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME | ABHD6, ABHD16A, ACSL6 | MGLL 24/4885ABHD6 1/4885PLA2G7 305/4885 |
| US-10030020-B2 | Spirocycle compounds and methods of making and using same | ABHD6, ABHD16A, ACSL6 | MGLL 24/4885ABHD6 1/4885PLA2G7 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.